This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Academia Sinica. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Chih-Hsuan Tsai in Viral Detection and Vaccination
Introduction
Chih-Hsuan Tsai is a notable inventor based in Pingtung, Taiwan. He has made significant contributions to the field of viral detection and vaccination through his innovative research and patents. His work focuses on the development of recombinant viruses and insect cells, which have important applications in medical diagnostics and treatment.
Latest Patents
Chih-Hsuan Tsai holds a patent for "Recombinant viruses, insect cells and their uses in viral detection and vaccination." This patent describes recombinant viruses and/or insect cells that are suitable for detecting the infection of a pathogen in a biological sample of a test subject. The information derived from this detection can be used to diagnose whether the test subject is infected with the pathogen, allowing for appropriate treatment to be assigned. Additionally, the patent includes a vaccine for the prophylaxis and/or treatment of infections caused by the pathogen. He has 1 patent to his name.
Career Highlights
Chih-Hsuan Tsai is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to engage in cutting-edge research and contribute to advancements in the field of virology.
Collaborations
Chih-Hsuan Tsai has collaborated with notable colleagues, including Yu-Chan Chao and Huei-Ru Lo. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Chih-Hsuan Tsai's contributions to viral detection and vaccination highlight the importance of innovation in medical science. His work not only advances our understanding of pathogens but also provides valuable tools for diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
